The Asia Pacific Protein Engineering Market would witness market growth of 16.7% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Protein Engineering Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $544.2 million by 2031. The Japan market is registering a CAGR of 15.9% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 17.4% during (2024 - 2031).
Protein engineering has made it possible for industrial biotechnology to take advantage of novel opportunities to enhance the efficiency and sustainability of a wide variety of industrial processes. Engineered enzymes are at the forefront of this revolution, finding applications in biofuel production, bioplastics synthesis, and food processing. As biological catalysts, enzymes offer remarkable specificity and efficiency, making them ideal for industrial applications.
Similarly, this engineering has greatly benefited the production of bioplastics derived from biodegradable renewable resources. By engineering enzymes that facilitate the polymerization of lactic acid into polylactic acid (PLA), a common bioplastic, researchers have developed more efficient and sustainable production processes. This innovation addresses the growing environmental concerns associated with conventional plastics, offering a greener alternative that reduces reliance on fossil fuels and minimizes plastic pollution.
The growing prevalence of chronic diseases in India is a driving force behind the demand for engineering solutions. According to estimates provided by the Indian Council of Medical Research, chronic diseases are responsible for approximately sixty percent of all deaths that occur in India. Among these, diabetes, cancer, and cardiovascular diseases are the most prevalent. As a result, engineering products and technologies have a substantial market opportunity to develop novel diagnostics and therapeutics for these diseases. Waste treatment is another area where this engineering is making a significant impact in this region. Engineered enzymes enhance the breakdown of organic waste in wastewater treatment plants. This not only improves the efficiency of waste treatment but also reduces the environmental footprint of these processes. In Japan, companies like Hitachi Zosen Corporation are developing advanced wastewater treatment systems that utilize engineered enzymes to degrade organic pollutants more effectively. Hence, the aforementioned trends will spur the expansion of the market throughout the forecast period.
Based on Product, the market is segmented into Instruments, Reagents, and Software & Services. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic Research Institutes. Based on Technology, the market is segmented into Rational Protein Design, Hybrid Approach, Directed Evolution, De Novo Protein Design, and Others. Based on Protein Type, the market is segmented into Monoclonal Antibodies, Insulin, Vaccines, Growth Factors, Interferon, Colony Stimulating Factors, Coagulation Factors, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Protein Engineering Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $544.2 million by 2031. The Japan market is registering a CAGR of 15.9% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 17.4% during (2024 - 2031).
Protein engineering has made it possible for industrial biotechnology to take advantage of novel opportunities to enhance the efficiency and sustainability of a wide variety of industrial processes. Engineered enzymes are at the forefront of this revolution, finding applications in biofuel production, bioplastics synthesis, and food processing. As biological catalysts, enzymes offer remarkable specificity and efficiency, making them ideal for industrial applications.
Similarly, this engineering has greatly benefited the production of bioplastics derived from biodegradable renewable resources. By engineering enzymes that facilitate the polymerization of lactic acid into polylactic acid (PLA), a common bioplastic, researchers have developed more efficient and sustainable production processes. This innovation addresses the growing environmental concerns associated with conventional plastics, offering a greener alternative that reduces reliance on fossil fuels and minimizes plastic pollution.
The growing prevalence of chronic diseases in India is a driving force behind the demand for engineering solutions. According to estimates provided by the Indian Council of Medical Research, chronic diseases are responsible for approximately sixty percent of all deaths that occur in India. Among these, diabetes, cancer, and cardiovascular diseases are the most prevalent. As a result, engineering products and technologies have a substantial market opportunity to develop novel diagnostics and therapeutics for these diseases. Waste treatment is another area where this engineering is making a significant impact in this region. Engineered enzymes enhance the breakdown of organic waste in wastewater treatment plants. This not only improves the efficiency of waste treatment but also reduces the environmental footprint of these processes. In Japan, companies like Hitachi Zosen Corporation are developing advanced wastewater treatment systems that utilize engineered enzymes to degrade organic pollutants more effectively. Hence, the aforementioned trends will spur the expansion of the market throughout the forecast period.
Based on Product, the market is segmented into Instruments, Reagents, and Software & Services. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic Research Institutes. Based on Technology, the market is segmented into Rational Protein Design, Hybrid Approach, Directed Evolution, De Novo Protein Design, and Others. Based on Protein Type, the market is segmented into Monoclonal Antibodies, Insulin, Vaccines, Growth Factors, Interferon, Colony Stimulating Factors, Coagulation Factors, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- Bruker Corporation
- Thermo Fisher Scientific, Inc.
- Waters Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Danaher Corporation
- Genscript Biotech Corporation
- Amgen, Inc.
- Promega Corporation
Market Report Segmentation
By Product- Instruments
- Reagents
- Software & Services
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
- Rational Protein Design
- Hybrid Approach
- Directed Evolution
- De Novo Protein Design
- Others
- Monoclonal Antibodies
- Insulin
- Vaccines
- Growth Factors
- Interferon
- Colony Stimulating Factors
- Coagulation Factors
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Protein Engineering Market by Product
Chapter 5. Asia Pacific Protein Engineering Market by End-use
Chapter 6. Asia Pacific Protein Engineering Market by Technology
Chapter 7. Asia Pacific Protein Engineering Market by Protein Type
Chapter 8. Asia Pacific Protein Engineering Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Bruker Corporation
- Thermo Fisher Scientific, Inc.
- Waters Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Danaher Corporation
- Genscript Biotech Corporation
- Amgen, Inc.
- Promega Corporation
Methodology
LOADING...
